These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32870822)

  • 1. LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
    Yeboah M; Papagregoriou C; Jones DC; Chan HTC; Hu G; McPartlan JS; Schiött T; Mattson U; Mockridge CI; Tornberg UC; Hambe B; Ljungars A; Mattsson M; Tews I; Glennie MJ; Thirdborough SM; Trowsdale J; Frendeus B; Chen J; Cragg MS; Roghanian A
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32870822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils.
    Zhao Y; van Woudenbergh E; Zhu J; Heck AJR; van Kessel KPM; de Haas CJC; Aerts PC; van Strijp JAG; McCarthy AJ
    J Immunol; 2020 Feb; 204(4):954-966. PubMed ID: 31915259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors.
    López-Álvarez MR; Jones DC; Jiang W; Traherne JA; Trowsdale J
    Immunogenetics; 2014 Feb; 66(2):73-83. PubMed ID: 24257760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.
    Huang R; Liu X; Kim J; Deng H; Deng M; Gui X; Chen H; Wu G; Xiong W; Xie J; Lewis C; Homsi J; Yang X; Zhang C; He Y; Lou Q; Smith C; John S; Zhang N; An Z; Zhang CC
    Cancer Immunol Res; 2024 Mar; 12(3):350-362. PubMed ID: 38113030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
    Mai S; Hodges A; Chen HM; Zhang J; Wang YL; Liu Y; Nakatsu F; Wang X; Fang J; Xu Y; Davidov V; Kang K; Pingali SR; Ganguly S; Suzuki M; Konopleva M; Prinzing B; Zu Y; Gottschalk S; Lu Y; Chen SH; Pan PY
    Cancer Res; 2023 Dec; 83(24):4047-4062. PubMed ID: 38098451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.
    Wu G; Xu Y; Schultz RD; Chen H; Xie J; Deng M; Liu X; Gui X; John S; Lu Z; Arase H; Zhang N; An Z; Zhang CC
    Nat Cancer; 2021 Nov; 2(11):1170-1184. PubMed ID: 35122056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.
    Jones DC; Hewitt CR; López-Álvarez MR; Jahnke M; Russell AI; Radjabova V; Trowsdale AR; Trowsdale J
    Oncotarget; 2016 Mar; 7(13):15618-31. PubMed ID: 26769854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.
    Bashirova AA; Apps R; Vince N; Mochalova Y; Yu XG; Carrington M
    Immunogenetics; 2014 Jan; 66(1):1-8. PubMed ID: 24096970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the hybrid gene
    Hirayasu K; Khor SS; Kawai Y; Shimada M; Omae Y; Hasegawa G; Hashikawa Y; Tanimoto H; Ohashi J; Hosomichi K; Tajima A; Nakamura H; Nakamura M; Tokunaga K; Hanayama R; Nagasaki M
    Front Immunol; 2024; 15():1398935. PubMed ID: 38807600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.
    Bashirova AA; Kasprzak W; O'hUigin C; Carrington M
    Immunogenetics; 2023 Jun; 75(3):263-267. PubMed ID: 36449053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.
    Hirayasu K; Sun J; Hasegawa G; Hashikawa Y; Hosomichi K; Tajima A; Tokunaga K; Ohashi J; Hanayama R
    J Hum Genet; 2021 Jul; 66(7):739-748. PubMed ID: 33526815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chicken immunoregulatory Ig-like receptor families: an overview and expression details on ggTREM-A1.
    Viertlboeck BC; Hanczaruk MA; Amann B; Bader SR; Schmitt R; Sperling B; Schwarz SC; Schmahl W; Deeg CA; Göbel TW
    Dev Comp Immunol; 2013 Nov; 41(3):403-12. PubMed ID: 23648646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
    Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
    Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Role of the Leucocyte Immunoglobulin-Like Receptors in Kidney Transplant Rejection: A Mini Review.
    Palvair J; Farhat I; Chaintreuil M; Dal Zuffo L; Messager L; Tinel C; Lamarthée B
    Transpl Int; 2024; 37():12995. PubMed ID: 39010891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 17. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
    Zhang W; Liang S; Wu J; Horuzsko A
    Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
    Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
    J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
    Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
    Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte Immunoglobulin-Like Receptors (LILRs) on Human Neutrophils: Modulators of Infection and Immunity.
    Lewis Marffy AL; McCarthy AJ
    Front Immunol; 2020; 11():857. PubMed ID: 32477348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.